NCT06074094View on ClinicalTrials.gov

Probiotic Supplementation IN NAFLD Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 12, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

March 1, 2023

Conditions
NAFLD
Interventions
DRUG

Control Test

Lacteol fort 10 billion which contains culture medium and lactobacillus LS as active ingredients

Trial Locations (1)

11517

Ain Shams University, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06074094 - Probiotic Supplementation IN NAFLD Patients | Biotech Hunter | Biotech Hunter